|
|
||||||||
Vol. 273, Issue 4, C1371-C1377, October 1997
-Adrenergic regulation of constitutive nitric oxide
synthase in cardiac myocytes
1 Department of Biomedical Engineering, Duke University, Durham, North Carolina 27708; 3 Division of Cardiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213; 4 Department of Physiology, University of North Carolina-Chapel Hill School of Medicine, Chapel Hill, North Carolina 27599; and 2 Department of Chemistry, Oakland University, Rochester, Michigan 48309
Nitric oxide (NO) has been implicated in endogenous control of
myocardial contractility. However, NO release has not yet been demonstrated in cardiac myocytes. Accordingly, endogenous NO production was measured with a porphyrinic microsensor positioned on the surface
of individual neonatal or adult rat ventricular myocytes (n > 6 neonatal and adult cells per
experiment). In beating neonatal myocytes, there was no detectable
spontaneous NO release with each contraction. However, norepinephrine
(NE; 0.25-1 µM) elicited transient NO release from beating
neonatal (149 ± 11 to 767 ± 83 nM NO) and noncontracting adult
(157 ± 13 to 791 ± 89 nM NO) cells. NO was released by
adrenergic agonists with the following rank order of potency:
isoproterenol
(
1
2) > NE (
/
1) > dobutamine (
1)
epinephrine
(
/
1
2) > tertbutylene (
2); NO was
not released by phenylephrine (
). NE-evoked NO release was
reversibly blocked by
NG-monomethyl-L-arginine,
trifluoperazine, guanosine
5'-O-(2-thiodiphosphate), and
nifedipine but was enhanced by 3-isobutyl-1-methylxanthine (0.5 mM = 14.5 ± 1.6%) and BAY K 8644 (10 µM = 11.9 ± 1%). NO was
also released by A-23187 (10 µM = 884 ± 88 nM NO), guanosine 5'-O-(3-thiotriphosphate) (1 µM = 334 ± 56 nM
NO), and dibutyryl adenosine 3',5'-cyclic monophosphate
(10-100 µM = 35 ± 9 to 284 ± 49 nM NO) but not by ATP,
bradykinin, carbachol, 8-bromoguanosine 3',5'-cyclic
monophosphate, or shear stress. This first functional demonstration of
a constitutive NO synthase in cardiac myocytes suggests its regulation
by a
-adrenergic signaling pathway and may provide a novel mechanism
for the coronary artery vasodilatation and enhanced diastolic
relaxation observed with adrenergic stimulation.
norepinephrine;
-adrenergic agonists; nitric oxide-selective
porphyrinic microsensor
This article has been cited by other articles:
![]() |
F. A. Faucher, F. E. Gannier, J. M. Lignon, P. Cosnay, and C. O. Malecot Roles of PKA, PI3K, and cPLA2 in the NO-mediated negative inotropic effect of {beta}2-adrenoceptor agonists in guinea pig right papillary muscles Am J Physiol Cell Physiol, January 1, 2008; 294(1): C106 - C117. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Casadei The emerging role of neuronal nitric oxide synthase in the regulation of myocardial function Exp Physiol, November 1, 2006; 91(6): 943 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. G Wang, E. N Dedkova, X Ji, L. A Blatter, and S. L Lipsius Phenylephrine acts via IP3-dependent intracellular NO release to stimulate L-type Ca2+ current in cat atrial myocytes J. Physiol., August 15, 2005; 567(1): 143 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Peterson, A. J. Kanai, and L. L. Pearce A mitochondrial role for catabolism of nitric oxide in cardiomyocytes not involving oxymyoglobin Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H55 - H58. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Wink, K. M. Miranda, T. Katori, D. Mancardi, D. D. Thomas, L. Ridnour, M. G. Espey, M. Feelisch, C. A. Colton, J. M. Fukuto, et al. Orthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: a novel redox paradigm Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2264 - H2276. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Brutsaert Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity Physiol Rev, January 1, 2003; 83(1): 59 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kojda and K. Kottenberg Regulation of basal myocardial function by NO Cardiovasc Res, March 1, 1999; 41(3): 514 - 523. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |